Gilead Sciences Inc.

NASDAQ: GILD · Real-Time Price · USD
118.24
-0.78 (-0.66%)
At close: Aug 15, 2025, 12:38 PM

Gilead Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
7.08B 6.67B 7.57B 7.54B 6.95B 6.69B 7.11B 7.05B 6.6B 6.35B 7.39B 7.04B 6.26B 6.59B 7.24B 7.42B 6.22B 6.42B
Cost of Revenue
1.5B 1.54B 1.58B 1.57B 1.54B 1.55B 2.09B 1.56B 1.44B 1.4B 1.4B 1.4B 1.44B 1.42B 2.63B 1.22B 1.39B 1.36B
Gross Profit
5.58B 5.13B 5.99B 5.97B 5.41B 5.13B 5.02B 5.49B 5.16B 4.95B 5.99B 5.65B 4.82B 5.17B 4.62B 6.2B 4.83B 5.06B
Operating Income
2.47B 2.24B 2.45B 888M 2.64B -4.32B 1.61B 2.62B 1.67B 1.71B 2.27B 2.84B 2.03B 197M 940M 3.84B 2.25B 2.89B
Interest Income
73M 94M 85M 52M 35M 108M n/a 106M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
2.43B 1.65B 2.17B 956M 2.05B -4.49B 1.65B 2.32B 1.59B 1.3B 2.03B 2.43B 1.5B -152M 759M 3.44B 1.82B 2.26B
Net Income
1.96B 1.31B 1.78B 1.25B 1.61B -4.17B 1.43B 2.18B 1.04B 1.01B 1.64B 1.79B 1.14B 19M 382M 2.59B 1.52B 1.73B
Selling & General & Admin
1.36B 1.26B 1.86B 1.43B 1.38B 1.38B 1.58B 1.31B 1.85B 1.32B 2.02B 1.21B 1.36B 1.08B 1.65B 1.19B 1.35B 1.05B
Research & Development
1.49B 1.38B 1.64B 1.4B 1.35B 1.52B 1.41B 1.46B 1.41B 1.45B -1.15B 1.15B 1.1B 3.88B 2.03B 1.1B 1.09B 1.05B
Other Expenses
250M 253M 34M 2.25B 37M 6.56B 424M 90M 236M 480M 2.86B 448M 330M 8M n/a 65M 138M 62M
Operating Expenses
3.11B 2.89B 3.54B 5.08B 2.77B 9.46B 3.41B 2.86B 3.49B 3.25B 3.73B 2.81B 2.79B 4.97B 3.68B 2.36B 2.58B 2.17B
Interest Expense
254M 260M 249M 238M 237M 254M 252M 232M 230M 230M 226M 229M 242M 238M 238M 250M 256M 257M
Selling & Marketing Expenses
864M 753M 869M n/a 805M 743M 826M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
4.61B 4.43B 5.12B 6.66B 4.31B 11.01B 5.5B 4.43B 4.93B 4.65B 5.12B 4.21B 4.23B 6.39B 6.3B 3.58B 3.97B 3.53B
Income Tax Expense
468M 334M 385M -297M 438M -315M 237M 146M 549M 316M 398M 646M 368M -164M 383M 852M 300M 542M
Shares Outstanding (Basic)
1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.26B 1.25B 1.26B 1.26B 1.25B 1.26B
Shares Outstanding (Diluted)
1.25B 1.26B 1.26B 1.25B 1.25B 1.25B 1.26B 1.26B 1.26B 1.26B 1.26B 1.26B 1.26B 1.26B 1.26B 1.26B 1.26B 1.26B
EPS (Basic)
1.57 1.06 1.43 1.00 1.29 -3.34 1.15 1.75 0.84 0.81 1.31 1.43 0.91 0.01 0.30 2.06 1.21 1.38
EPS (Diluted)
1.56 1.04 1.42 1.00 1.29 -3.34 1.14 1.73 0.83 0.80 1.30 1.42 0.91 0.01 0.30 2.05 1.21 1.37
EBITDA
3.37B 2.6B 3.11B 1.88B 2.98B -3.54B 2.59B 3.23B 2.5B 2.17B 2.79B 3.19B 2.27B 611M 1.53B 4.21B 2.59B 2.99B
EBIT
2.68B 1.91B 2.42B 1.19B 2.29B -4.23B 1.91B 2.55B 1.82B 1.53B 2.26B 2.66B 1.75B 86M 997M 3.69B 2.07B 2.52B
Depreciation & Amortization
691M 696M 693M 690M 694M 690M 688M 684M 681M 640M 528M 525M 525M 525M 535M 523M 519M 473M